Answers are grounded in this paper and cite their sources.
Dyslipidemia is a chronic non-communicable disease (CNCD), induced by abnormalities in lipid metabolism resulting from excess intake of cholesterol, trans and saturated fats. Dyslipidemia is indicated by increased plasma total cholesterol, low-density lipoprotein (LDL) and triglyceride levels, and lower high-density lipoprotein (HDL) levels. Common treatments for dyslipidemia do not indicate ideal plasma cholesterol levels for every patient, which means better treatment is required. Some species
No takes yet. Share an insight, caveat, or question.
Fu’adah et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: